FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

AuroMedics Pharma Levetiracetam in 0 Recall

Levetiracetam in 0

AuroMedics Pharma LLC · East Windsor, NJ

Risk level
Class II
Reported by FDA
May 9, 2018
Recall ID
D-0706-2018
Check your lot numberHow we source this data

Summary

AuroMedics Pharma recalled Levetiracetam in 0 starting Mar 27, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0706-2018 on May 9, 2018. Reason: Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap

Product description

Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg per 100 mL (10 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-247-47.

Lot numbers, UPCs & expiration codes

Lot/Batch #'s: CLV160013, CLV160014 and CLV160015, exp Sept 2018; CLV160022, CLV160023, CLV160024, CLV160025, CLV160026, CLV160027, CLV160028, CLV160029, CLV160030 exp Oct 2018; CLV170002, Dec 2018; CLV170010, exp April 2019; CLV170027, CLV170028, CLV170029 and CLV170030 exp Oct 2019

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0706-2018
Classification
Class II
Status
Terminated
Recall initiated
Mar 27, 2018
FDA report date
May 9, 2018
Quantity
188941 bags
Recall type
Voluntary: Firm initiated
Recalling firm
AuroMedics Pharma LLC

Original FDA data

Every field from FDA enforcement report D-0706-2018, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
79772
Address
279 Princeton Hightstown Rd
Code information
Lot/Batch #'s: CLV160013, CLV160014 and CLV160015, exp Sept 2018; CLV160022, CLV160023, CLV160024, CLV160025, CLV160026, CLV160027, CLV160028, CLV160029, CLV160030 exp Oct 2018; CLV170002, Dec 2018; CLV170010, exp April 2019; CLV170027, CLV170028, CLV170029 and CLV170030 exp Oct 2019
Postal code
08520-1401
Report date
May 9, 2018
Product type
Drugs
Recall number
D-0706-2018
Classification
Class II
Recalling firm
AuroMedics Pharma LLC
Product quantity
188941 bags
Termination date
Feb 18, 2022
Reason for recall
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg per 100 mL (10 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-247-47.
Distribution pattern
US Nationwide
Recall initiation date
Mar 27, 2018
Initial firm notification
Letter
Center classification date
May 3, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0706-2018, published May 9, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls